Testimonials From Value Pricing for Market Access

Really good fundamental course! It’s broad and high level. Thanks!

Allergan

Deirdre Murphy, Manager, Pricing & Reimbursement - United Kingdom - October 2017
I would like to thank you for the training quality and level of the trainer. The presentation was very interactive. The hotel and facilities also were above expectations.

Amgen

Mohammed Sedrati, Senior Market Access Manager - Morocco - October 2017
This course gives a very comprehensive overview about the most important topics within value pricing.

LEO Pharma

Ingrid Möll, Head of RA & Compliance - Switzerland - May 2017
This course is truly great. I can highly recommend it. It is a must for everyone starting his/her career in the field of pricing & market access.

Incyte Biosciences

Yan Agalarov, Senior Analyst, Pricing, Market Access and Commercial Partnerships - Switzerland - May 2017
Very valuable course with a great expert! I now have a wide perspective on pharma pricing and learnt a lot. I will definitely recommend it to others!

Sanofi

Ewelina Bernaszuk, Junior HEOR and Pricing Specialist - Poland - December 2016
Gary’s course is high standard. He smoothly links value pricing with market access.

AOP Orphan Pharmaceuticals

Khalil Wehbe, Marketing Manager Middle East - United Arab Emirates - December 2016
Gary Johnson's vast knowledge and experience is very well structured into an instructive, yet easy to follow course. Excellent course material provided as well.

Fresenius Kabi

Sampreet Ramachandra, Director, Anaesthesia & Analgesia - Germany - December 2016
This is a very good introductory course on pharmaceutical pricing and Gary is an excellent instructor. As usual, C.E.L.forpharma has picked a winner. I am really impressed by your speakers. All have been extremely knowledgeable AND excellent speakers!

Novo Nordisk

Anirvan Dutt-Chaudhuri, Global Product Manager - Switzerland - September 2016
Very interactive, high level though accessible course. Gary is an excellent speaker and the discussions with participants were very insightful!

Novartis

Christophe Gerbeau, Early Phase Market Access SPE - France - September 2016
Very insightful and well-structured two days of walking through the main topics of value pricing in Market Access, using a simple language that all are able to follow, even if you are not an expert in the area.

Almirall

Paula Albuquerque, Global Market Access & Health Outcomes Manager - Spain - September 2016
Very satisfied and happy to have spent these 2 days. I learnt a lot about pharmaceutical pricing and enjoyed the good spirit of the group!

Sanofi

Asmara Karzazi, Market Access Project Leader - France - June 2016
I learnt a lot on this whistle-stop tour of the pharma pricing fundamentals. Gary is a highly knowledgeable trainer who can simplify the most complex subjects.

Astellas

Lorraine Tweddle, Associate Brand Director - United Kingdom - June 2016
C.E.L.forpharma’s Value Pricing for Market Access course is very informative, insightful and conceptually interesting, offering valuable tips & insights for everyday work.

Janssen

Maja Grdić Jarak, Strategic Pricing Manager EMEA - Croatia - June 2016
Extremely practical pharma pricing course, addressing the real issues that pharma companies face!

Baxter

Neeraj Sinha, Senior Pricing Analyst - Switzerland - June 2016
This was a great and useful course. I would recommend it to everyone involved in pricing pharmaceuticals. It covers most of the important aspects and concepts along the price decision process, with valuable exercises and practical techniques.

Accord Healthcare

Olga Diachenko, Commercial Analyst - Czech Republic - June 2016
As a beginner in the field of pharma pricing and market access, Gary Johnson’s course enabled me to have in only 2 days a 30,000 feet view of the different problematics and leave with concrete usable tools. I highly recommend it!

Legacy Healthcare

Saad Harti, CEO - Switzerland - June 2016
A very informative and interesting course given by a lecturer with great depth of knowledge... Thank you!

Xellia Pharmaceuticals

Beate Rygg Johnsen, Portfolio Manager - Norway - December 2015
This course is an essential ingredient for Pricing & Market Access functions.

Boehringer Ingelheim

Jean-Gabriel Gautier, Head of Global Pricing & Contracting Strategy, TA Biosimilars/ Global Market Access - Germany - December 2015
My peers and I have used C.E.L.forpharma for many years now. I recently attended a Value Pricing for Market Access course in Europe, led by a real pro in this area and I learned a great deal. Not only was the course excellently delivered but I also got the opportunity to network with a number of key Market Access Leaders in the Industry to share thoughts, ideas and challenges. I would definitely recommended C.E.L. to anyone involved in Market Access.

Parexel

Oliver Leatham, Principal Consultant Commercialization - UK - August 2015
It was a great pleasure to attend this course. This was the best pharma pricing course I have done anyway. Gary was outstanding in describing the link between value and expected price of pharmaceuticals. Good job and I wish you good luck!

Saudi FDA

Fahad Sahood AlNutafy, Director Pricing & Pharmacoeconomic Directorate - Saudi Arabia - May 2015
It was a pleasure learning from probably the #1 pricing expert in the pharmaceutical industry. Gary brings a wealth of experience and insights, and besides that he is a warm and personal person. Really appreciated the course!

Teva

Jelmer Nicolai, Market Access Manager Respiratory - The Netherlands - May 2015
Very valuable course. Excellent overview of Value Access Tools, Techniques and Models for a straight forward use back at work.

AstraZeneca

Sandrine Ruiz, Global Market Access Manager - Spain - May 2015
Very good pharma pricing course, great structure and outcome. Excellent!

Grifols

Steffen Mager, Senior Manager International Market Access - Germany - May 2015
Very valuable course, interesting subjects and a well experienced lector. The Value Pricing for Market Access course was so practical and applicable to my role. Bravo Gary, bravo C.E.L.forpharma. Highly recommended!

Novo Nordisk Pars

Alireza Firooz, Market Access Specialist - Iran - December 2014
Great training with much information that is relevant and important to managers in pharma pricing and market access. Huge knowledge and experience presented in a very simple and understandable way!

Eli Lilly

Milena Randjelovic, PRA and Sales Manager - Serbia - December 2014
Great course, well presented with practical advice. Highly recommended!

Boehringer Ingelheim

James Gordon, Global Manager HE&OR - Germany - October 2014
Gary Johnson is a very good teacher! Even if you have been practicing Pricing and Market Access for a long time, his course helps you to synthesize all your knowledge and open your horizon.

Galderma

Pol-Antoine Hamon, Market Access Manager Non Melanoma Skin Cancer - France - October 2014
Good introductory course, at the right level, with a very knowledgeable trainer and a good opportunity for discussion.

UCB

Rebecca Townsend, Global Market Access Director - Belgium - October 2014
Great overview, putting things in perspective. I would recommend to attend this course!

Astellas

Daan Muris, Associate Director Market Access - The Netherlands - June 2014
Thank you very much for a very good course and for interesting, useful information!

Novartis

Anna Blednykh, Pricing Manager - Russia - March 2014
A great introductory course for anyone who is new in the field of pricing. Good breadth and overview of the discipline. Gary is an expert with vast experience demonstrated in his lectures and anecdotes.

Novartis

Tuan Pham, Director Strategic Planning - Switzerland - March 2014
Very interesting and transversal subject. Gary's presentation is clear with self explanatory slides.

Servier

Anne Boudon, Price Department Manager - France - December 2013
The course did an excellent job in providing an overview of the role of pricing, complexity in payer decision making and research tools available.

Lundbeck

Christian Mosegaard Hansen, Associate Global Pricing Manager - Denmark - December 2013
Well experienced lector, the subject was explained deeply in a variety of directions and from different perspectives.

Temapharm

Michal Szymanowski, Business Development Manager - Poland - December 2013
Very valuable course - excellent introduction to the area and very professionally run.

Servier

Neil Branscombe, Director of Health Economics - France - December 2013
Good organization, especially the time keeping! Gary Johnson covered this subject surprisingly well in this short time frame!

Novo Nordisk

Adam Garczarczyk, Senior Pricing Manager - Switzerland - October 2013
Thank you for this course! It was a great opportunity to pull everything together that I have been working on the last year. I will highly recommend to colleagues who enter the international pricing field.

Boehringer Ingelheim

Mary Beth Webb, Pricing Manager for CoE CV/Respiratory - Germany - October 2013
Gary is a very experienced lecturer. He has the ability to explain issues explicitly and makes everything understandable by using lots of examples.

AstraZeneca

Tina Orben, Market Access Manager - Germany - October 2013